{"id": "375628", "url": "https://fevir.net/resources/Evidence/375628", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/intervention-only-evidence"], "versionId": "12", "lastUpdated": "2025-08-05T19:05:44.774Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>[No data.]</p></div>", "status": "empty"}, "title": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group", "author": [{"name": "Brian S. Alper, MD, MSPH"}], "citeAs": "Evidence for Results for Systolic blood pressure at 12 weeks in QUARTET USA Trial Quadpill group [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375628. Revised 2025-08-05. Available at: https://fevir.net/resources/Evidence/375628. Computable resource at: https://fevir.net/resources/Evidence/375628#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "relatesTo": [{"type": "part-of", "targetReference": {"type": "Composition", "display": "Outcome Measure Report for QUARTET USA Trial", "reference": "Composition/375280"}}], "statistic": [{"quantity": {"unit": "mm Hg", "value": 122.3}, "sampleSize": {"knownDataCount": 29, "numberOfParticipants": 32, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/number-analyzed", "valueUnsignedInt": 32}]}, "statisticType": {"coding": [{"code": "STATO:0000573", "system": "https://fevir.net/sevco", "display": "mean"}]}, "attributeEstimate": [{"type": {"coding": [{"code": "STATO:0000196", "system": "https://fevir.net/sevco", "display": "confidence interval"}]}, "level": 0.95, "range": {"low": {"unit": "mm Hg", "value": 118.2}, "high": {"unit": "mm Hg", "value": 126.5}}}]}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "375628", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "description": "Mean systolic blood pressure of 122.3  mm Hg with 95% CI of (118.2 mm Hg,126.5 mm Hg)", "resourceType": "Evidence", "variableDefinition": [{"observed": {"type": "Group", "display": "QUARTET USA Trial Quadpill group", "reference": "Group/375175"}, "variableRole": "population"}, {"observed": {"type": "EvidenceVariable", "display": "Systolic blood pressure at 12 weeks", "reference": "EvidenceVariable/375185"}, "variableRole": "outcome"}], "name": "Evidence_for_Results_for_Systolic_blood_pressure_at_12_weeks_in_QUARTET_USA_Trial_Quadpill_group"}